Liver Support Peptides: Structural Classification and Bioactivity Analysis
Title: Liver Support Peptides: Structural Classification and Bioactivity Analysis Abstract: Liver support peptides, classified by chain length and amino acid composition (e.g., di-, tri-, and oligopeptides), exhibit hepatoprotective bioactivity via antioxidant and anti-inflammatory pathways. Market trends show a 12.3% CAGR (2023–2030), driven by functional food and nutraceutical demand. Key brands (e.g., Thorne, Pure Encapsulations) differ in purity (>95% vs. 85%) and sourcing (plant vs. synthetic). Technical advantages include high bioavailability and targeted delivery; limitations involve enzymatic degradation and cost. Product parameters (molecular weight <1 kDa, solubility >90%) and certifications (GMP, NSF, ISO 22000) guide selection. Logistics require cold-chain storage (2–8°C) to maintain stability. Industry analysis highlights fragmented manufacturing with 60% of factories lacking GMP compliance, emphasizing rigorous supplier audits.